FASEB BioAdvances : Impact Factor & More

eISSN: 2573-9832pISSN: 2573-9832
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

FASEB BioAdvances Key Metrics

CiteScore
2.6
SNIP
0.77
Time to Publish
time-to-publish View Chart
3
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
36%
4 to 6 months
50%
7 to 9 months
7%
Above 9 months
7%

Topics Covered on FASEB BioAdvances

Ablation
genomic DNA
Learning environment
Cardiovascular care
Medical education
Biomedical sciences
Extracellular vesicles
Educational leadership
Immune system
Cancer gene
Pandemic
Urine
Medical curriculum
Student engagement
Medulloblastoma
Obstructive sleep apnea
Mutant
Overlap syndrome
Positive deviance
Vismodegib

FASEB BioAdvances Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2200 | GBP 1850 | USD 2400
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorFederation of American Societies for Experimental Biology
FrequencyMonthly
Publication Start Year2019
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in FASEB BioAdvances ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in FASEB BioAdvances

Compare Similar Journals with FASEB BioAdvances

Select Journals to Compare with FASEB BioAdvances
Total journals - 7
You can select up to 3 Journals at a time

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Scientific Reports

Publisher: NATURE PORTFOLIO

Academic Medicine

Publisher: LIPPINCOTT WILLIAMS & WILKINS

International Journal of Environmental Research and Public Health

Publisher: Multidisciplinary Digital Publishing Institute (MDPI)

International Journal of Molecular Sciences

Publisher: MDPI

Frontiers in Immunology

Publisher: FRONTIERS MEDIA SA

Proceedings of the National Academy of Sciences of the United States of America

Publisher: NATL ACAD SCIENCES
0 Journals Selected to compare with
FASEB BioAdvances
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in FASEB BioAdvances?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on FASEB BioAdvances

How long has FASEB BioAdvances been actively publishing? Faqs

FASEB BioAdvances has been in operation since 2019 till date.

What is the publishing frequency of FASEB BioAdvances? Faqs

FASEB BioAdvances published with a Monthly frequency.

How many articles did FASEB BioAdvances publish last year? Faqs

In 2023, FASEB BioAdvances publsihed 50 articles.

What is the eISSN & pISSN for FASEB BioAdvances? Faqs

For FASEB BioAdvances, eISSN is 2573-9832 and pISSN is 2573-9832.

What is Citescore for FASEB BioAdvances? Faqs

Citescore for FASEB BioAdvances is 2.6.

What is SNIP score for FASEB BioAdvances? Faqs

SNIP score for FASEB BioAdvances is 0.77.

Who is the publisher of FASEB BioAdvances? Faqs

WILEY is the publisher of FASEB BioAdvances.